WEBULL
News
CDXI
0.0005
NaN%
--
Weekly Report: what happened at CDXI last week (0202-0206)?
Weekly Report · 3d ago
Weekly Report: what happened at CDXI last week (0126-0130)?
Weekly Report · 02/02 10:16
Weekly Report: what happened at CDXI last week (0119-0123)?
Weekly Report · 01/26 10:16
Weekly Report: what happened at CDXI last week (0112-0116)?
Weekly Report · 01/19 10:22
Weekly Report: what happened at CDXI last week (0105-0109)?
Weekly Report · 01/12 10:21
Weekly Report: what happened at CDXI last week (1229-0102)?
Weekly Report · 01/05 10:15
Weekly Report: what happened at CDXI last week (1222-1226)?
Weekly Report · 12/29/2025 10:15
Weekly Report: what happened at CDXI last week (1215-1219)?
Weekly Report · 12/22/2025 10:14
Weekly Report: what happened at CDXI last week (1208-1212)?
Weekly Report · 12/15/2025 10:21
Weekly Report: what happened at CDXI last week (1201-1205)?
Weekly Report · 12/08/2025 10:20
Weekly Report: what happened at CDXI last week (1124-1128)?
Weekly Report · 12/01/2025 10:16
Weekly Report: what happened at CDXI last week (1117-1121)?
Weekly Report · 11/24/2025 10:20
Weekly Report: what happened at CDXI last week (1110-1114)?
Weekly Report · 11/17/2025 10:20
Weekly Report: what happened at CDXI last week (1103-1107)?
Weekly Report · 11/10/2025 10:18
Weekly Report: what happened at CDXI last week (1027-1031)?
Weekly Report · 11/03/2025 10:18
Weekly Report: what happened at CDXI last week (1020-1024)?
Weekly Report · 10/27/2025 10:21
Weekly Report: what happened at CDXI last week (1013-1017)?
Weekly Report · 10/20/2025 10:18
Weekly Report: what happened at CDXI last week (1006-1010)?
Weekly Report · 10/13/2025 10:21
Weekly Report: what happened at CDXI last week (0929-1003)?
Weekly Report · 10/06/2025 10:17
Weekly Report: what happened at CDXI last week (0922-0926)?
Weekly Report · 09/29/2025 10:19
More
Webull provides a variety of real-time CDXI stock news. You can receive the latest news about Cardax Inc through multiple platforms. This information may help you make smarter investment decisions.
About CDXI
Cardax, Inc. is a geroscience company focused on pharmaceutical and nutraceutical applications of astaxanthin. The Company markets ZanthoSyn, an astaxanthin dietary supplement for lifespan and health span (inflammatory health), including joint and muscle function, cognitive performance, and cardiovascular health. ZanthoSyn is available through its commercial Website. ZanthoSyn contains pure astaxanthin prepared by natural product total synthesis. The Company is also advancing CDX-101, its pharmaceutical candidate, for the diseases of aging. CDX-101 is an astaxanthin Rx candidate for cardiovascular inflammation and dyslipidemia. CDX-301 is its zeaxanthin pharmaceutical candidate for macular degeneration. It may seek to monetize its CDX-301 pharmaceutical assets through licensing or sale.